Floatz logo

Mtr-601

Cerebral Palsy

Motric BioUNKNOWNPhase 1Active
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Cerebral Palsy cohort.

Asset / SponsorPhaseRating
Ropivacaine
University of California, Los Angeles
Phase 4BB
Trihexyphenidyl
Sathbhavana Brain Clinic
Phase 4BB
Tetrabenazine
Sathbhavana Brain Clinic
Phase 4BB
Dexmedetomidine
Joseph Cravero
Phase 4BB
Lamotrigine
Sathbhavana Brain Clinic
Phase 4BB

View all 23 →

Same molecule, other indications

Mtr-601 is also rated in:

dystonic disorderActive
CC
Indicative · Phase 1
47 / 100
View asset →
spinal cord injuryActive
CC
Indicative · Phase 1
47 / 100
View asset →
multiple sclerosisActive
CC
Indicative · Phase 1
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →